Dr. Barry Alan Schechter, MD

Dr. Schechter practices at Boynton Beach ASC in Boynton Beach, Florida.

Dr. Schechter's NPI, 1487716494, was assigned on December 15, 2006. Dr. Schechter graduated from SUNY Downstate Health Sciences University in 1988. Dr. Schechter holds Florida license ME62041.

Dr. Schechter's primary practice is Boynton Beach ASC, at 1717 Woolbright Road, Boynton Beach, FL 33426. The practice phone is (561) 737-8031.

Dr. Schechter's primary practice is Boynton Beach ASC in Boynton Beach, Florida. Dmand AI also links Dr. Schechter to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schechter practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Schechter's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Schechter is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Schechter's licenses on file in 2 states: Florida and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Schechter treats.

CMS data shows 10,730 Medicare services from Dr. Schechter across 35 procedure codes in 2024, for 1,884 Medicare patients. Medicare paid $775,743 for them.

CMS counts 1,884 Medicare patients who saw Dr. Schechter in 2024. The largest group is 75 to 84, with 948 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schechter's median patient age at 77, with 60% women.

In 2024, Dr. Schechter wrote 3,934 Medicare Part D claims for 1,180 patients. 39% of them were for generic drugs. CMS names the drug for 3,820 of them, across 41 drugs with 11 or more claims each, at $1,512,118 in total drug cost. In 2023, CMS named 4,111 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Schechter for performance year 2024, reported as part of a group. Dr. Schechter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 476 procedures of cataract surgery by Dr. Schechter, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Schechter, published from 2006 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Ophthalmic Solutions, Administration, Topical and Antineoplastic Agents. Dr. Schechter has published most often in Cornea. Dr. Schechter's most frequent co-authors are Jodi Ian Luchs, MD, Robert S. Smyth-Medina, MD and Jason Bacharach, MD.

Dmand AI links Dr. Schechter to 6 clinical trials, 3 of them phase 4 studies. Conditions studied include Dry Eye Syndromes, Lacrimal Apparatus Diseases and Hyperemia. Innovative Medical sponsors the most, 2.

CMS Open Payments shows 860 general payments to Dr. Schechter from 39 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 29% of the total. Sun Pharmaceutical Industries Inc. paid the most, $115,030. It also lists 1 research payment totaling $18,000 in 2017.

Dmand AI lists 2 awards for Dr. Schechter.

Dr. Schechter graduated from SUNY Downstate Health Sciences University in 1988. Dr. Schechter is a member of AAO.

Dr. Schechter is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.